Medical Management of Early Pregnancy Failure: Efficacy

Beatrice A. Chen; Mitchell D. Creinin

doi:10.1055/s-0028-1087107

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2008; 26(5): 411-422
DOI: 10.1055/s-0028-1087107

Medical Management of Early Pregnancy Failure: Efficacy

Beatrice A. Chen¹ , Mitchell D. Creinin¹ ^, ²

¹Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
²Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania

Abstract

ABSTRACT

Early pregnancy failure is a common pregnancy complication. This article reviews the efficacy of medical management of early pregnancy failure. Nonsurgical treatments, including expectant and medical management, are reasonable alternatives to surgical management depending on the clinical situation and the patient's requests. Possible regimens in medical management of early pregnancy failure include misoprostol alone or mifepristone in conjunction with misoprostol. However, many studies of medical management may underestimate success rates due to inconsistent inclusion criteria, different dosing regimens, and varying definitions of failed treatment. Clinicians need to understand the range of efficacy of these regimens to provide appropriate counseling to patients.

KEYWORDS

Early pregnancy failure - miscarriage - missed abortion - misoprostol - mifepristone

Volltext

Referenzen

REFERENCES

1 Hemminki E. Treatment of miscarriage: current practice and rationale. Obstet Gynecol. 1998; 91 247-253
2 Warburton D, Fraser F C. Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit. Am J Hum Genet. 1964; 16 1-25
3 Creinin M D, Schwartz J L, Guido R S, Pymar H C. Early pregnancy failure–current management concepts. Obstet Gynecol Surv. 2001; 56 105-113
4 Creinin M D, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol. 1997; 89(5 Pt 1) 768-772
5 Gronlund A, Gronlund L, Clevin L et al.. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark. Acta Obstet Gynecol Scand. 2002; 81 1060-1065
6 Bagratee J S, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod. 2004; 19 266-271
7 Zalányi S. Vaginal misoprostol alone is effective in the treatment of missed abortion. Br J Obstet Gynaecol. 1998; 105 1026-1028
8 Zhang J, Gilles J M, Barnhart K et al.. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005; 353 761-769
9 Creinin M D. Medical abortion regimens: historical context and overview. Am J Obstet Gynecol. 2000; 183(2, Suppl) S3-S9
10 Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet. 1995; 345 84-86
11 Callen P W. Ultrasonography in Obstetrics and Gynecology. 4th ed. Philadelphia, PA; WB Saunders 2000
12 Harwood B, Meckstroth K R, Mishell D R, Jain J K. Serum beta-human chorionic gonadotropin levels and endometrial thickness after medical abortion. Contraception. 2001; 63 255-256
13 Reynolds A, Ayres-de-Campos D, Costa M A, Montenegro N. How should success be defined when attempting medical resolution of first-trimester missed abortion?. Eur J Obstet Gynecol Reprod Biol. 2005; 118 71-76
14 Creinin M D, Harwood B, Guido R S et al.. Endometrial thickness after misoprostol use for early pregnancy failure. Int J Gynaecol Obstet. 2004; 86 22-26
15 Luise C, Jermy K, Collons W P, Bourne T H. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol. 2002; 19 580-582
16 Reeves M F, Lohr P A, Harwood B J, Creinin M D. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure. Obstet Gynecol. 2008; 111 106-112
17 Cowett A A, Cohen L S, Lichtenberg E S, Stika C S. Ultrasound evaluation of the endometrium after medical termination of pregnancy. Obstet Gynecol. 2004; 103(5 Pt 1) 871-875
18 Ngoc N TN, Blum J, Westheimer E, Quan T TV, Winikoff B. Medical treatment of missed abortion using misoprostol. Int J Gynaecol Obstet. 2004; 87 138-142
19 Gilles J M, Creinin M D, Barnhart K et al.. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure. Am J Obstet Gynecol. 2004; 190 389-394
20 Tang O S, Lau W NT, Ng E HY, Lee S WH, Ho P C. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriages. Hum Reprod. 2003; 18 176-181
21 Tang O S, Ong C YT, Tse K Y et al.. A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Hum Reprod. 2006; 21 189-192
22 Phupong V, Taneepanichskul S, Kriengsinyot R et al.. Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion. Contraception. 2004; 70 307-311
23 Nguyen T N, Blum J, Durocher J, Quan T TV, Winikoff B. A randomized controlled study comparing 600 versus 1,200 μg oral misoprostol for medical management of incomplete abortion. Contraception. 2005; 72 438-442
24 Wood S L, Brain P H. Medical management of missed abortion: a randomized clinical trial. Obstet Gynecol. 2002; 99 563-566
25 Blohm F, Friden B E, Milsom I, Platz-Christensen J J, Nielsen S. A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage. BJOG. 2005; 112 1090-1095
26 Weeks A, Alia G, Blum J et al.. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol. 2005; 106 540-547
27 Bique C, Ustá M, Debora B et al.. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. Int J Gynaecol Obstet. 2007; 98 222-226
28 Shwekerela B, Kalumuna R, Kipingili R et al.. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. , [see comment] BJOG. 2007; 114 1363-1367
29 Demetroulis C, Saridogan E, Kunde D, Naftalin A A. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Hum Reprod. 2001; 16 365-369
30 Muffley P E, Stitely M L, Gherman R B. Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. Am J Obstet Gynecol. 2002; 187 321-325
31 Graziosi G CM, Mol B WJ, Reuwer P JH, Drogtrop A, Bruinse H W. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Hum Reprod. 2004; 19 1894-1899
32 Creinin M D, Huang X, Westhoff C et al.. Factors related to successful misoprostol treatment for early pregnancy failure. Obstet Gynecol. 2006; 107 901-907
33 Asch R H, Weckstein L N, Balmaceda J P et al.. Non-surgical expulsion of non-viable early pregnancy: a new application of RU 486. Hum Reprod. 1990; 5 481-483
34 Nielsen S, Hahlin M, Platz-Christensen J J. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue. Br J Obstet Gynaecol. 1997; 104 1094-1096
35 Coughlin L B, Roberts D, Haddad N G, Long A. Medical management of first trimester miscarriage (blighted ovum and missed abortion): is it effective?. J Obstet Gynaecol. 2004; 24 69-71
36 Wagaarachchi P T, Ashok P W, Narvekar N, Smith N C, Templeton A. Medical management of early fetal demise using a combination of mifepristone and misoprostol. Hum Reprod. 2001; 16 1849-1853
37 Schaff E A, Fielding S L, Eisinger S H, Stadalius L S, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception. 2000; 61 41-46
38 Creinin M D, Fox M C, Teal S et al.. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol. 2004; 103(5 Pt 1) 851-859
39 Lelaidier C, Baton-Saint-Mleux C, Fernandez H, Bourget P, Frydman R. Mifepristone (RU 486) induces embryo expulsion in first trimester non-developing pregnancies: a prospective randomized trial. Hum Reprod. 1993; 8 492-495
40 Nielsen S, Hahlin M, Platz-Christensen J. Randomised trial comparing expectant with medical management for first trimester miscarriages. Br J Obstet Gynaecol. 1999; 106 804-807
41 Stockheim D, Machtinger R, Wiser A et al.. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure. Fertil Steril. 2006; 86 956-960
42 Niinimäki M, Jouppila P, Martikainen H, Talvensaari-Mattila A. A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage. Fertil Steril. 2006; 86 367-372
43 Schreiber C A, Creinin M D, Reeves M F, Harwood B J. Mifepristone and misoprostol for the treatment of early pregnancy failure: a pilot clinical trial. Contraception. 2006; 74 458-462
44 Trinder J, Brocklehurst P, Porter R et al.. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment [MIST] trial). BMJ. 2006; 332 1235-1240
45 Shelley J M, Healy D, Grover S. A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage. Aust N Z J Obstet Gynaecol. 2005; 45 122-127
46 Grønlund L, Grønlund A-L, Clevin L et al.. Spontaneous abortion: expectant management, medical treatment or surgical evacuation. Acta Obstet Gynecol Scand. 2002; 81 781-782

Beatrice A ChenM.D.

Assistant Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine

Magee-Womens Hospital, 300 Halket Street, Pittsburgh, PA 15213

eMail: chenba@upmc.edu